Related Experiment Video
Updated: Mar 21, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Conflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing
Luke I Rast1,2, Igor M Rouzine1, Ganna Rozhnova1
1Gladstone Institutes (Virology and Immunology), San Francisco, California, United States of America.
Therapeutic Interfering Particles (TIPs) can control HIV evolution. Engineered TIPs prevent the spread of resistant HIV mutants by exploiting evolutionary tradeoffs, offering a potential long-term solution for HIV/AIDS.
Area of Science:
- Virology
- Evolutionary Biology
- Computational Modeling
Background:
- Rapid evolution of RNA viruses like HIV challenges conventional treatments and vaccines.
- Therapeutic Interfering Particles (TIPs) were proposed as engineered molecular parasites to control HIV indefinitely.
- A key question is whether TIPs can maintain resistance-proof control at a population scale against transmissible HIV mutants.
Purpose of the Study:
- To model and assess the population-scale efficacy of Therapeutic Interfering Particles (TIPs) against HIV evolution.
- To determine if TIPs can provide indefinite control of HIV by preventing the spread of TIP-resistant mutants.
Main Methods:
- Development of a multi-scale mathematical model to simulate HIV evolution under TIP pressure.
- Analysis of evolutionary tradeoffs associated with HIV developing resistance to TIPs.
- Simulation of viral protein production, replication fitness, and transmission rates in treated and untreated subpopulations.
Main Results:
- TIP-resistant HIV mutants exhibit reduced transmission in TIP-untreated populations.
- TIP-resistant HIV mutants display decreased replicative fitness in both TIP-treated and untreated individuals.
- TIP-susceptible HIV strains consistently outcompete TIP-resistant mutants when TIPs express >3-fold more genomic RNA than HIV.
Conclusions:
- Evolutionary tradeoffs inherently prevent the widespread transmission of TIP-resistant HIV mutants.
- TIPs can maintain indefinite control of HIV at both patient and population levels under specific design constraints.
- Findings provide crucial design parameters for developing population-scale therapies resistant to antiviral drug escape.
Related Concept Videos
Viruses with RNA Genomes
Retrovirus Life Cycles
Viral Mutations
Inhibitors of Viral Protein Synthesis
Size and Structure of Viral Genomes
The Antiviral System of Bacteria and Archaea: CRISPR

